IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 372 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 0 | – | 0.00% | – |
| Q2 2023 | $0 | – | 0 | – | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2021 | $296,000 | -71.8% | 7,417 | -68.2% | 0.00% | -71.4% |
| Q1 2021 | $1,048,000 | -18.7% | 23,300 | +2.2% | 0.01% | -22.2% |
| Q4 2020 | $1,289,000 | +20.2% | 22,800 | +0.9% | 0.01% | +12.5% |
| Q3 2020 | $1,072,000 | -19.5% | 22,600 | 0.0% | 0.01% | -27.3% |
| Q2 2020 | $1,332,000 | +24.6% | 22,600 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $1,069,000 | -11.5% | 22,600 | +13.0% | 0.01% | 0.0% |
| Q4 2019 | $1,208,000 | +0.8% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $1,198,000 | -6.8% | 20,000 | 0.0% | 0.01% | -15.4% |
| Q2 2019 | $1,285,000 | – | 20,000 | – | 0.01% | – |
| Q1 2019 | $0 | – | 0 | – | 0.00% | – |
| Q4 2018 | $0 | – | 0 | – | 0.00% | – |
| Q4 2017 | $0 | – | 0 | – | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2016 | $313,000 | -42.5% | 13,420 | 0.0% | 0.01% | -40.0% |
| Q1 2016 | $544,000 | -28.1% | 13,420 | +9.8% | 0.01% | -33.3% |
| Q4 2015 | $757,000 | – | 12,220 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
| DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
| Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
| WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
| PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
| Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
| Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
| Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
| PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |